Cargando…

Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review

Icariin is a biologically active substance in Epimedii herba that is used for the treatment of neurologic disorders. However, a comprehensive analysis of the molecular mechanisms of icariin is lacking. In this review, we present a brief history of the use of icariin for medicinal purposes; describe...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Shuangqiu, Ma, Jiarui, Zeng, Yanqi, Zhou, Guowei, Wang, Yuxuan, Zhou, Wenjuan, Sun, Xiaohe, Wu, Minghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384151/
https://www.ncbi.nlm.nih.gov/pubmed/34447243
http://dx.doi.org/10.2147/DDDT.S310686
_version_ 1783741857868546048
author Wang, Shuangqiu
Ma, Jiarui
Zeng, Yanqi
Zhou, Guowei
Wang, Yuxuan
Zhou, Wenjuan
Sun, Xiaohe
Wu, Minghua
author_facet Wang, Shuangqiu
Ma, Jiarui
Zeng, Yanqi
Zhou, Guowei
Wang, Yuxuan
Zhou, Wenjuan
Sun, Xiaohe
Wu, Minghua
author_sort Wang, Shuangqiu
collection PubMed
description Icariin is a biologically active substance in Epimedii herba that is used for the treatment of neurologic disorders. However, a comprehensive analysis of the molecular mechanisms of icariin is lacking. In this review, we present a brief history of the use of icariin for medicinal purposes; describe the active chemical components of Epimedii herba; and examine the evidence from experimental studies that have uncovered molecular targets of icariin in different diseases. We also constructed a protein–protein interaction network and carried out Gene Ontology and Kyoto Encyclopedia of Genes and Genomes functional enrichment analyses to predict the therapeutic actions of icariin in nervous system diseases including Alzheimer disease, Parkinson disease, ischemic stroke, depressive disorder, multiple sclerosis, glioblastoma, and hereditary spastic paraplegias. The results of our analyses can guide future studies on the application of icariin to the treatment of neurologic disorders.
format Online
Article
Text
id pubmed-8384151
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-83841512021-08-25 Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review Wang, Shuangqiu Ma, Jiarui Zeng, Yanqi Zhou, Guowei Wang, Yuxuan Zhou, Wenjuan Sun, Xiaohe Wu, Minghua Drug Des Devel Ther Review Icariin is a biologically active substance in Epimedii herba that is used for the treatment of neurologic disorders. However, a comprehensive analysis of the molecular mechanisms of icariin is lacking. In this review, we present a brief history of the use of icariin for medicinal purposes; describe the active chemical components of Epimedii herba; and examine the evidence from experimental studies that have uncovered molecular targets of icariin in different diseases. We also constructed a protein–protein interaction network and carried out Gene Ontology and Kyoto Encyclopedia of Genes and Genomes functional enrichment analyses to predict the therapeutic actions of icariin in nervous system diseases including Alzheimer disease, Parkinson disease, ischemic stroke, depressive disorder, multiple sclerosis, glioblastoma, and hereditary spastic paraplegias. The results of our analyses can guide future studies on the application of icariin to the treatment of neurologic disorders. Dove 2021-08-20 /pmc/articles/PMC8384151/ /pubmed/34447243 http://dx.doi.org/10.2147/DDDT.S310686 Text en © 2021 Wang et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Wang, Shuangqiu
Ma, Jiarui
Zeng, Yanqi
Zhou, Guowei
Wang, Yuxuan
Zhou, Wenjuan
Sun, Xiaohe
Wu, Minghua
Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review
title Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review
title_full Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review
title_fullStr Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review
title_full_unstemmed Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review
title_short Icariin, an Up-and-Coming Bioactive Compound Against Neurological Diseases: Network Pharmacology-Based Study and Literature Review
title_sort icariin, an up-and-coming bioactive compound against neurological diseases: network pharmacology-based study and literature review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8384151/
https://www.ncbi.nlm.nih.gov/pubmed/34447243
http://dx.doi.org/10.2147/DDDT.S310686
work_keys_str_mv AT wangshuangqiu icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview
AT majiarui icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview
AT zengyanqi icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview
AT zhouguowei icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview
AT wangyuxuan icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview
AT zhouwenjuan icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview
AT sunxiaohe icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview
AT wuminghua icariinanupandcomingbioactivecompoundagainstneurologicaldiseasesnetworkpharmacologybasedstudyandliteraturereview